Kyanna Sabanoglu

Summary — Kyanna Sabanoglu (Patent Litigation Practice)

Specialty and firm context. Sabanoglu is an IP litigator whose tracked practice reflects a mix of Hatch-Waxman pharmaceutical litigation and high-tech patent defense. Her single tracked appearance is Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. et al. (D. Del.), where she served as plaintiff-side trial counsel at Gibson, Dunn & Crutcher. Public docket records also show her at Gibson Dunn representing Dell entities against NPE WSOU Investments in Judge Albright's W.D. Tex. courtroom, and practice profiles describe her Gibson Dunn work spanning telecommunications and pharma. She began her career at Milbank LLP under IP litigator Errol Taylor, moved to Gibson Dunn, and joined Meta in February 2022 as Lead Counsel of IP Litigation, later promoted to Associate General Counsel for IP Litigation (Law.com; Modern Counsel). At Meta she manages high-profile AI-related litigation, including the copyright suit over Llama training data and the patent suit brought by Dialect over AI-assistant technology.

Side preference. The tracked data shows one plaintiff-side appearance (1-0), but that understates a genuinely two-sided career: she defended operating companies (Dell) against NPE assertions at Gibson Dunn and now leads defense-side IP litigation in-house at Meta. Her practice is best characterized as representing innovative companies on both offense and defense, with current work focused on defending a major platform company against patent and copyright claims.

Notable cases and outcomes. In Novartis v. Accord, the court held U.S. Patent No. 9,187,405 (Gilenya/fingolimod) valid and infringed after a bench trial, entered a permanent injunction, and set the ANDA approval date no earlier than the patent's June 25, 2027 expiration — a significant Hatch-Waxman win for Novartis and Dana-Farber. She also appeared pro hac vice in the companion Novartis cases against Dr. Reddy's (D. Del. 21-cv-1105/1106/1107). I could not verify the Federal Circuit outcome of the Accord appeal within available sources.

PTAB/IPR and credentials. Her PTAB exposure appears limited rather than regular: one verifiable appearance as patent-owner counsel in PGR2021-00002 (Evergreen Theragnostics v. Advanced Accelerator Applications). She is admitted in New York (FindLaw profile), with a B.A. from Franklin & Marshall College and a J.D. from Cardozo School of Law (per third-party profile; not independently confirmed against a primary source). She also holds a CIPP privacy certification (2023, per Modern Counsel).